OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.390
+0.200 (4.77%)
Aug 20, 2026, 12:49 PM EDT - Market open
OmniAb Market Cap
OmniAb has a market cap or net worth of $638.26 million as of August 20, 2026. Its market cap has increased by 158.79% in one year.
Market Cap
638.26M
Enterprise Value
605.18M
1-Year Change
158.79%
Ranking
Category
Stock Price
$4.39
ChartMarket Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $638.26M, a decrease of -35.72%. That is a compound annual growth rate of -10.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 569.93M | 114.00% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 610.84M |
| Arvinas | 598.28M |
| ARS Pharmaceuticals | 590.72M |
| Prelude Therapeutics | 590.16M |
| Altimmune | 581.61M |
| Artiva Biotherapeutics | 573.73M |
| Eikon Therapeutics | 568.73M |
| Adlai Nortye | 568.00M |